Lumexa Imaging Holdings, Inc. Common Stock
LMRI
NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.2B
$12.18
▲ +2.35%
P/E
-20.72
Mkt Cap
$1.2B
52-Wk Range
$6.45–$19.45
52-Week Range
$6.45 - $19.45
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 34.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Efficient outpatient imaging center model with lower overhead costs
- Comprehensive service portfolio attracting diverse patient populations
- Strategic geographic positioning in high-demand markets
- Growing network scale creating operational synergies
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Rising demand for preventive healthcare and early disease detection
Value
Attractively priced below sector peer average
Momentum
Hot
+49.8% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying LMRI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 12, 2026
Reported EPS of $0.20 vs $0.15 consensus (+34.9% surprise). Revenue of $264.2M vs $263.1M expected (+0.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+34.9%
Revenue trend · last 4Q
—
+8%
—
—
Q4 24
Q4 25
Q1 26
Q2 26
$248.0M
$267.7M
$252.5M
$264.2M
Margins · last 4Q
Gross
-9.4%
Operating
14.4%
Profit
1.0%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 28, 2026
vs Industry
How LMRI stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.